Aimee M. Freeman

发表

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Richard D Moore, R. Hogg, S. Gange, 2007, International journal of epidemiology.

Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014

Richard D Moore, M. Lindegren, B. Musick, 2017, Journal of the International AIDS Society.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Sally S Bebawy, Richard D Moore, J. Goedert, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.

Richard D Moore, Jennifer S. Lee, S. Cole, 2020, The Journal of infectious diseases.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, The Journal of infectious diseases.

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale

M. Yotebieng, S. Olsson, P. Braitstein, 2016, Drug Safety.

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Richard D Moore, K. Anastos, O. Kirk, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ascertainment and Verification of End-Stage Renal Disease and End-Stage Liver Disease in the North American AIDS Cohort Collaboration on Research and Design

Richard D Moore, S. Gange, G. Lucas, 2015, AIDS research and treatment.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Michael J Silverberg, Bryan Lau, Michael S Saag, 2009, The New England journal of medicine.

One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States

Sally S Bebawy, Richard D Moore, Jennifer S. Lee, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.

Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States

Sally S Bebawy, Richard D Moore, K. Anastos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium

B. Musick, D. Nash, A. Kimmel, 2022, medRxiv.

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.

Richard D Moore, J. Goedert, B. Lau, 2011, The Journal of infectious diseases.

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.

Richard D Moore, Jennifer S. Lee, J. Margolick, 2019, The lancet. HIV.

Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment

Richard D Moore, T. Sterling, D. Dowdy, 2016, Journal of acquired immune deficiency syndromes.

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, Clinical Infectious Diseases.

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Sally S Bebawy, Richard D Moore, J. Goedert, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

End-stage renal disease among HIV-infected adults in North America.

Sally S Bebawy, K. Anastos, S. Gange, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016

Jun Yu Li, S. Gange, J. Willig, 2023, PloS one.

The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

J. Goedert, B. Lau, R. Hogg, 2009 .

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Sally S Bebawy, K. Anastos, S. Gange, 2013, The Journal of infectious diseases.